北京交大思诺科技股份有限公司部分募集资金投资项目结项 并将结余募集资金永久补充流动资金的核查意见 国信证券股份有限公司（以下简称"国信证券"、"保荐机构"）作为北京 交大思诺科技股份有限公司（以下简称"公司"、"交大思诺"）首次公开发行 股票并在深圳证券交易所创业板上市的保荐机构，根据《证券发行上市保荐业务 管理办法》、《上市公司监管指引第 2 号—上市公司募集资金管理和使用的监 管要求（2022 年修订）》、《深圳证券交易所上市公司自律监管指引第 2 号— 创业板上市公司规范运作》、《深圳证券交易所创业板股票上市规则》等相关规 定，对公司部分募集资金投资项目结项并将结余募集资金永久补充流动资金事项 进行了核查，具体情况如下： 一、募集资金基本情况 （一）募集资金基本情况 国信证券股份有限公司关于 经中国证券监督管理委员会证监许可〔2020〕712 号文核准，并经深圳证券 交易所同意，公司由主承销商国信证券采用余额包销方式，向社会公众公开发行 人民币普通股（A 股）股票 2,173.34 万股，发行价每股人民币 28.69 元，共计募 集资金 62,353.12 万元，坐扣承销和保荐费用 5,800.00 万 ...

国信证券股份有限公司 关于北京交大思诺科技股份有限公司 使用闲置自有资金进行现金管理的核查意见 国信证券股份有限公司（以下称"国信证券"）作为北京交大思诺科技股份 有限公司（以下简称"公司"、"交大思诺"）首次公开发行股票并在创业板上 市的保荐机构，根据《证券发行上市保荐业务管理办法》、《深圳证券交易所创业 板股票上市规则》、《深圳证券交易所上市公司自律监管指引第 2 号——创业板上 市公司规范运作》等相关法律、法规和规范性文件的规定，就交大思诺使用闲置 自有资金进行现金管理的事项进行了审慎核查，具体情况如下: 为进一步提高资金使用效率，公司于 2024 年 1 月 11 日召开第三届董事会第 十八次会议和第三届监事会第十七次会议，审议通过了《关于使用闲置自有资金 进行现金管理的议案》，同意公司（含子公司，下同）在确保不影响公司正常运 营的情况下，使用合计不超过 60,000 万元（含本数）自有资金进行现金管理，使 用期限自第三届董事会第十八次会议审议通过之日起 12 个月内有效，在上述额 度内，资金可以循环滚动使用。同时公司董事会授权公司董事长或董事长授权人 士在上述额度内签署相关合同文件，包括但不限于选择 ...

证券代码： 300851 证券简称：交大思诺 公告编号：2024-003 北京交大思诺科技股份有限公司 关于使用闲置自有资金进行现金管理的公告 本公司及除董事何青外的董事会全体成员保证信息披露的内容真实、准确、 完整，没有虚假记载、误导性陈述或重大遗漏。 董事何青因病缺席第三届董事会第十八次会议。 北京交大思诺科技股份有限公司（以下简称"公司"或"交大思诺"）于2024 年1月11日召开第三届董事会第十八次会议和第三届监事会第十七次会议，审议 通过了《关于使用闲置自有资金进行现金管理的议案》，本议案在董事会审议范 围内，无需提交股东大会审议。同意公司（含子公司，下同）在确保不影响公司 正常运营的情况下，使用合计不超过60,000万元（含本数）自有资金进行现金管 理，使用期限自第三届董事会第十八次会议审议通过之日起12个月内有效，在上 述额度内，资金可以循环滚动使用。同时公司董事会授权公司董事长或董事长授 权人士在上述额度内签署相关合同文件，包括但不限于选择合格的理财产品发行 主体、明确理财金额、选择理财产品品种、签署合同等，公司财务部负责组织实 施。现将详细情况公告如下： 一、本次使用闲置自有资金进行现金管理 ...

证券代码：300851 证券简称：交大思诺 公告编号：2024-001 北京交大思诺科技股份有限公司 第三届董事会第十八次会议决议公告 本公司及除董事何青外的董事会全体成员保证信息披露的内容真实、准确、 完整，没有虚假记载、误导性陈述或重大遗漏。 董事何青因病缺席第三届董事会第十八次会议。 一、董事会会议召开情况 1、北京交大思诺科技股份有限公司(以下简称"公司")第三届董事会第十八次 会议通知于2024年1月2日通过电子邮件、书面通知形式送达全体董事，同时列明 了会议的召开时间、内容和方式。 2、本次董事会于2024年1月11日在公司会议室召开，以现场结合通讯表决方 式进行(其中董事徐迅、李晓东、许文龙、向东、毕克以通讯表决方式参加会议)。 3、本次董事会应出席董事12名，实际出席董事11名，缺席会议的董事1人， 董事何青因病缺席会议。 4、本次董事会由董事长李伟先生召集和主持，公司监事和部分高级管理人 员列席了本次董事会。 5、本次会议的召集、召开和表决程序符合《中华人民共和国公司法》等法 律法规和《北京交大思诺科技股份有限公司章程》的有关规定。 二、董事会会议审议情况 经与会董事认真审议，形成决议如下： ...

Financial Performance - The company's operating revenue for Q3 2023 reached CNY 115,484,482.17, representing a year-on-year increase of 137.46%[5] - Net profit attributable to shareholders was CNY 29,961,783.36, up 244.09% compared to the same period last year[5] - The net profit after deducting non-recurring gains and losses was CNY 26,856,154.79, reflecting a significant increase of 1,340.61% year-on-year[5] - Basic and diluted earnings per share were both CNY 0.3447, marking a 244.01% increase from the previous year[5] - The net profit for Q3 2023 reached CNY 36,966,215.33, a significant increase of 78.3% compared to CNY 20,719,592.41 in Q3 2022[23] - Operating profit for the quarter was CNY 36,061,001.47, up from CNY 20,433,154.43, reflecting a growth of 76.5% year-over-year[23] - The total comprehensive income for the quarter was CNY 36,966,215.33, compared to CNY 20,719,592.41 in the same quarter last year, reflecting a growth of 78.3%[24] - Total revenue from operating activities was CNY 274,838,103.99, up from CNY 254,675,870.65, indicating a growth of 7.9% year-over-year[25] Assets and Liabilities - Total assets as of September 30, 2023, amounted to CNY 1,383,525,432.28, a 1.74% increase from the end of the previous year[5] - Current assets totaled ¥918,411,012.77 as of September 30, 2023, down from ¥1,051,259,158.62 at the beginning of the year, representing a decrease of 12.63%[19] - Non-current assets increased to ¥465,114,419.51 from ¥308,652,714.80, marking a significant growth of 50.67%[19] - Total liabilities rose to ¥137,273,563.31 from ¥120,909,547.58, reflecting an increase of 13.46%[20] - The company's cash and cash equivalents decreased to ¥96,355,117.62 from ¥156,032,277.40, a decline of 38.29%[19] Cash Flow - Cash flow from operating activities showed a net outflow of CNY 3,470,130.79, a decrease of 70.26% compared to the same period last year[11] - The cash flow from operating activities showed a net increase of CNY 3,470,130.79, down from CNY 11,667,782.51 in the previous year[27] - Investment activities resulted in a net cash outflow of CNY 39,232,686.11, an improvement from a net outflow of CNY 84,029,343.45 in the previous year[27] Shareholder Information - Total number of common shareholders at the end of the reporting period is 10,384[13] - The largest shareholder, Qiu Kuanmin, holds 24.04% of shares, totaling 20,898,000 shares[13] - The second-largest shareholder, Xu Xun, holds 11.83% of shares, totaling 10,284,000 shares[13] - The company has a total of 15,673,500 restricted shares held by Qiu Kuanmin, which are set to be released on July 17, 2023[15] - Xu Xun has 7,713,000 restricted shares, also set to be released on July 17, 2023[15] - Zhao Shengkai holds 5,220,000 shares, with 3,915,000 of them being restricted and set to be released on July 17, 2023[15] - The total number of restricted shares for Zhang Min is 4,422,000, with 3,316,500 being released on July 17, 2023[15] - The total number of restricted shares for Li Wei is 2,428,000, with 1,821,000 being released on July 17, 2023[15] - The company has a total of 52,321,800 restricted shares, with 45,939,728 being released[16] - The company has not disclosed any relationships or agreements among the top ten unrestricted shareholders[14] Operational Metrics - Total operating revenue for Q3 2023 reached ¥205,762,010.72, an increase of 18.06% compared to ¥174,362,076.73 in Q3 2022[22] - Total operating costs for Q3 2023 were ¥206,066,604.09, up from ¥184,051,554.12 in the same period last year, reflecting a year-over-year increase of 11.96%[22] - Accounts receivable increased to ¥207,445,335.65 from ¥203,958,335.68, showing a growth of 1.2%[19] - Inventory levels rose to ¥160,949,974.20 from ¥128,923,989.74, representing a significant increase of 24.87%[19] - The company's net profit margin was approximately 0.1% for Q3 2023, down from 0.18% in Q3 2022, indicating a decline in profitability[22] Research and Development - Research and development expenses increased to CNY 79,180,885.29, compared to CNY 67,287,583.83 in the same period last year, marking a rise of 17.7%[23] Audit and Reliability - The report was not audited, which may affect the reliability of the financial data presented[29] - The company’s total assets and liabilities were not detailed in the provided documents, indicating a focus on income statement metrics in this report[29]

证券代码：300851 证券简称：交大思诺 公告编号：2023-044 北京交大思诺科技股份有限公司 关于一致行动协议到期解除暨控股股东、实际控制人变更的 提示性公告 本公司股东邱宽民、徐迅、赵胜凯、张民、赵会兵、李伟保证向本公司提供 的信息内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 北京交大思诺科技股份有限公司（以下简称"公司"）于2023年10月25日收 到公司股东邱宽民、徐迅、赵胜凯、张民、赵会兵、李伟（以下简称"邱宽民等 六人"）签署的《一致行动协议终止协议》，解除上述各方基于《一致行动协议》 《<一致行动协议>之补充协议》（以下合称"原协议"）所形成的一致行动关系。 一致行动关系终止后，上述股东各自持有的公司股份数量和比例保持不变，公司 由邱宽民等六人共同控制变更为邱宽民先生一人控制，具体情况如下： 一、原协议签署及履行情况 为加强对公司的管理和控制，保持公司股权结构的稳定性，保持公司的重大 事项决策的一致性，邱宽民等六人于2013年5月4日签署了《一致行动协议》，于 2019年4月7日 ...

北京市天元律师事务所 关于北京交大思诺科技股份有限公司 相关股东一致行动协议终止暨实际控制人变更的 法律意见 北京市天元律师事务所 北京市西城区金融大街 35 号国际企业大厦 A座 509 单元 邮编：100033 北京市天元律师事务所 关于北京交大思诺科技股份有限公司 相关股东一致行动协议终止暨实际控制人变更的 法律意见 京天股字（2023）第 562 号 致：北京交大思诺科技股份有限公司 根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民共和 国证券法》（以下简称"《证券法》"）、《上市公司收购管理办法》（"以下简称 《收购管理办法》"）、《深圳证券交易所创业板股票上市规则》（以下简称"《创 业板股票上市规则》"）《证券期货法律适用意见第 17 号》等法律、法规和规范 性文件的规定及《北京交大思诺科技股份有限公司章程》（"以下简称《公司章 程》"）的有关规定，北京市天元律师事务所（以下简称"本所"）受北京交大思 诺科技股份有限公司（以下简称"公司"或"交大思诺"）委托，对公司提供的 相关文件及有关事实进行了核查和验证，就公司相关股东一致行动人协议终止 及实际控制人变更所涉事宜出具本法律意见 ...

证券代码：300851 证券简称：交大思诺 公告编号：2023-042 北京交大思诺科技股份有限公司 第三届监事会第十六次会议决议公告 经与会监事认真审议，形成决议如下： 审议通过《关于公司<2023 年第三季度报告>的议案》 经审议，监事会认为，公司《2023 年第三季度报告》符合法律、行政法规、 中国证券监督管理委员会和深圳证券交易所的相关规定，内容真实、准确、完整， 不存在任何虚假记载、误导性陈述或重大遗漏。 具体内容详见公司 2023 年 10 月 27 日刊载于中国证监会指定创业板信息披 露网站巨潮资讯网（www.cninfo.com.cn）上的《2023 年第三季度报告》（公告编 号：2023-043）。 表决结果：同意票 3 票、反对票 0 票、弃权票 0 票。 三、备查文件 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 北京交大思诺科技股份有限公司（以下简称"公司"）第三届监事会第十六 次会议通知已于 2023 年 10 月 18 日通过书面通知形式送达至全体监事。会议于 2023 年 10 月 25 日在公司会议室以 ...

证券代码：300851 证券简称：交大思诺 公告编号：2023-041 北京交大思诺科技股份有限公司 第三届董事会第十七次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 1、北京交大思诺科技股份有限公司(以下简称"公司")第三届董事会第十 七次会议通知于 2023 年 10 月 18 日通过电子邮件、书面通知等形式送达全体董 事，同时列明了会议的召开时间、内容和方式。 2、本次董事会于 2023 年 10 月 25 日在公司会议室召开，以现场结合通讯 表决方式进行(其中董事向东以通讯表决方式参加会议)。 3、本次董事会应出席董事 12 名，实际出席董事 12 名。 二、董事会会议审议情况 经与会董事认真审议，形成决议如下： 审议通过《关于公司<2023 年第三季度报告>的议案》 经审议，董事会认为，公司《2023 年第三季度报告》符合法律、行政法规、 中国证券监督管理委员会和深圳证券交易所的相关规定，内容真实、准确、完整， 不存在任何虚假记载、误导性陈述或重大遗漏。 具体内容详见公司 2023 年 10 月 27 日刊载于 ...

Financial Performance - The company reported a total revenue of RMB 200 million for the first half of 2023, representing a year-on-year increase of 15%[19]. - The net profit attributable to shareholders was RMB 30 million, up 20% compared to the same period last year[19]. - The company's operating revenue for the reporting period was ¥90,277,528.55, a decrease of 28.20% compared to the same period last year[25]. - The net profit attributable to shareholders was ¥8,491,540.49, down 36.29% year-on-year[25]. - The net cash flow from operating activities was -¥7,921,297.15, representing a decline of 184.50% compared to the previous year[25]. - The basic earnings per share decreased by 36.27% to ¥0.0977[25]. - The company reported a significant increase in inventory, which rose by 3.07% to 166,662,137.39 CNY, indicating potential challenges in sales[70]. - The company reported a total revenue of 53,286 million RMB for the first half of 2023, with a significant increase of 864.71% compared to the previous period[83]. - The company reported a total comprehensive income of 21,065,908.81 CNY for the current period, compared to a loss in the previous period, indicating a positive turnaround[194]. Research and Development - The company plans to invest RMB 50 million in R&D for new technologies and products in the next fiscal year[19]. - The company continues to focus on R&D, increasing investment to enhance product innovation and core competitiveness[33]. - Over 50% of the company's workforce is dedicated to research and development, ensuring a strong focus on innovation[54]. - The company is increasing its investment in product development and strengthening collaborations with industry leaders and universities[102]. - The company is committed to enhancing its research and development capabilities to improve product reliability and safety[98]. Market Strategy and Expansion - The company has outlined a market expansion strategy targeting Southeast Asia, aiming for a 10% market share by 2025[19]. - The company expects improvement in operational performance in the second half of 2023 as market demand gradually recovers[33]. - The company plans to expand its marketing network to diversify customer risk, as a high concentration of sales is observed among its top five customers[100]. - The company plans to focus on market expansion and new product development in the upcoming quarters, aiming to enhance revenue streams[194]. - The company is exploring potential mergers and acquisitions to strengthen its market position and diversify its offerings[194]. Risks and Challenges - The company has identified risks related to market competition and regulatory changes, with strategies in place to mitigate these risks[6]. - The company faces operational risks due to revenue fluctuations and seasonal variations, with a significant portion of revenue concentrated in the second half of the year[97]. - The company is exposed to risks from international trade tensions, particularly regarding the supply of electronic components from the U.S.[106]. - The company faces risks related to talent shortages in the technology sector, which could impact product development[104]. - The company relies on external suppliers for key manufacturing processes, with a high percentage of procurement from its top five suppliers, which poses a risk if any major supplier fails[100]. Corporate Governance and Compliance - The company has established a close and trustworthy cooperative relationship among its six key executives, enhancing corporate governance through various rules and systems[109]. - The company strictly adheres to laws and regulations, ensuring transparency and protecting shareholder rights[127]. - The company has not encountered any major changes in the feasibility of the projects or significant changes in the investment commitments[82]. - The company has not reported any changes in the purpose of raised funds, indicating stable financial management practices[80]. - The company has not faced any administrative penalties related to environmental issues during the reporting period, adhering strictly to environmental protection laws[125]. Investment and Financial Management - The company plans to continue focusing on cash management and optimizing its investment strategies to enhance profitability in the future[68]. - The total amount of raised funds is CNY 532.86 million, with a net amount of CNY 532.86 million after deducting issuance costs[80]. - The company has effectively managed idle raised funds, generating some income through cash management while ensuring project funding remains intact[84]. - The company has not used any raised funds to replace pre-invested self-raised funds, ensuring compliance with financial regulations[84]. - The company has allocated 29,557,356.00 CNY for dividend distribution, maintaining a consistent dividend policy[190].